In my previous post, I calculated something wrong enough which I thought need to be re-entered, so I self reported.
Back in March 2023 this webinar slide shows anticipated with willingness to use in approx 35% of the 2L patients
So of the 3.7M people currently seeking treatment for AHH, if they are willing to be tried at 1L or 2L, aiming for 35% seems high, but certainly very welcome if it comes to pass. 5 to 10% would be game changing
Full slide shown for reference below
BOT - Anything but charting, page-9297
-
- There are more pages in this discussion • 360 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $669.7M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 36.5¢ | $143.1K | 390.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 83326 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 58771 | 2 |
View Market Depth
| Last trade - 10.27am 15/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |